Alexandra Baehre

Title: The Innovative Contributions of Inventor Alexandra Baehre

Introduction

Alexandra Baehre is a prominent inventor hailing from Farum, Denmark. With four patents to her name, she has made significant strides in the field of biotechnology, particularly concerning human tear lipocalin and its applications in medicine.

Latest Patents

Among her latest innovations is the patented technology titled "Tear Lipocalin Muteins Binding IL-4 Receptor Alpha." This invention addresses the need for novel muteins derived from human tear lipocalin that bind effectively to the IL-4 receptor alpha. The patented sequences consist of specific combinations of amino acids, marking a major advancement in the therapeutic potential of tear lipocalin. Notably, mutated amino acid residues are identified at key sequence positions of the mature human tear lipocalin polypeptide, offering insights into targeted treatment methods. Additionally, this invention encompasses a nucleic acid molecule that encodes the mutein, as well as a method for producing both the mutein and its corresponding nucleic acid.

Career Highlights

Alexandra has worked with esteemed companies in the pharmaceutical sector, including Pieris Pharmaceuticals GmbH and AstraZeneca AB. Her experience in these organizations has contributed to her expertise in developing innovative biopharmaceutical solutions.

Collaborations

Throughout her career, Alexandra has collaborated with notable colleagues such as Andreas Hohlbaum and Gabriele Matschiner. These partnerships have undoubtedly enriched her research and development endeavors, fostering an environment of innovation and scientific advancement.

Conclusion

Alexandra Baehre's contributions to the field of biotechnology through her patents not only highlight her ingenuity as an inventor but also promise to enhance therapeutic options for patients. Her journey serves as an inspiring example of how dedication and collaboration can lead to impactful scientific discoveries.